Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001255294-14-001209
Filing Date
2014-11-21
Accepted
2014-11-21 12:16:16
Documents
11
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-K 343224
2 EX31_1 ex31_1.htm EX-31.1 9311
3 EX31_2 ex31_2.htm EX-31.2 9187
4 EX32_1 ex32_1.htm EX-32.1 4977
5 GRAPHIC image_001.jpg GRAPHIC 6179
  Complete submission text file 0001255294-14-001209.txt   1576069

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE atoa-20140731.xml EX-101.INS 82438
7 XBRL SCHEMA FILE atoa-20140731.xsd EX-101.SCH 16058
8 XBRL CALCULATION FILE atoa-20140731_cal.xml EX-101.CAL 21486
9 XBRL DEFINITION FILE atoa-20140731_def.xml EX-101.DEF 24132
10 XBRL LABEL FILE atoa-20140731_lab.xml EX-101.LAB 113632
11 XBRL PRESENTATION FILE atoa-20140731_pre.xml EX-101.PRE 94684
Mailing Address BIOCITY SCOTLAND, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY SCOTLAND, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 1698 53 9797
Altovida Inc. (Filer) CIK: 0001529293 (see all company filings)

EIN.: 452759045 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-176736 | Film No.: 141241930
SIC: 2834 Pharmaceutical Preparations